Thursday, October 22, 2020
Home Tags Phase

Tag: Phase

MediciNova, in Collaboration with the University of Sydney and the Australasian...

LA JOLLA, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and...

Allakos Announces Publication of Results from the Phase 2 Study of...

REDWOOD CITY, Calif., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Allakos Inc. (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment...

Global Minimally-invasive Surgery Devices Market Report 2020 by Key Players, Marketed...

“Minimally-invasive Surgery Devices Market” report provides strategic supports mentioned by the business specialists with market sources, amount of manufacturing cost structure, raw materials, forecasts,...

CinCor Pharma Announces First Patient Dosed with CIN-107 in Phase 2...

CINCINNATI, Oct. 20, 2020 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”), a clinical-stage biopharmaceutical company developing medications targeting cardiovascular disease, announced today...

Merck Presents Three-Year Survival Data for KEYTRUDA® (pembrolizumab) in Combination With...

In KEYNOTE-021 (Cohort G), first-line treatment with KEYTRUDA in combination with chemotherapy (n=60) demonstrated a significant improvement in objective response rates (58% vs. 33%),...

Evelo Biosciences Completes Enrollment in Phase 1b Clinical Trial Cohort Evaluating...

CAMBRIDGE, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered,...

Can-Fite to Host Conference Call to Update Shareholders on Positive Interim...

Oct. 13, 2020 11:00 UTC PETACH TIKVA, Israel--(BUSINESS WIRE)-- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small...

Investigational Agent Achieves All Secondary End Points in Phase 3 Study...

Omidubicel as treatment of patients with high-risk hematologic malignancies induced rapid platelet engraftment and a reduction in the number of infections and hospitalizations, meeting...

Mirikizumab Shows Continued Symptom Improvement and Reduction of Intestinal Inflammation in...

INDIANAPOLIS, Oct. 12, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) announced today new efficacy and safety data from the Phase 2 SERENITY study evaluating...

The Covid-19 pandemic is expected to further affect RhoVac’s clinical phase...

LUND, Sweden, Oct. 12, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today that the company's clinical phase IIb study in prostate cancer, a multi-center...
20,764FansLike
2,389FollowersFollow
16,600SubscribersSubscribe

EDITOR PICKS